Benefits of Morphine gel for pain reduction in patients with Cancer Wounds
Phase 2
- Conditions
- Head and Neck Neoplasms
- Registration Number
- RBR-3rqcxqd
- Lead Sponsor
- Escola de Enfermagem Aurora de Afonso Costa
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Patient enrolled in the unit; primary or metastatic breast or head and neck disease of any histological type; malignant neoplastic wound with stage II or greater; 18 years of age or older; karnofsky performance status greater than or equal to 30%; have at least 3 on the pain intensity scale; admission time of 48 hours or more; using systemic morphine
Exclusion Criteria
Fistulated wound; wound with extensive coagulation necrosis (more than 50% of the wound area); wound with exudation greater than 1 (pressure ulcer scale for healing); wound with bleeding greater than 1 (validated intraoperative bleeding scale); radiotherapy in progress in the wound
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method